-
Sajid Javid combats cancer crisis
pharmatimes
February 04, 2022
UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery.
-
Medicare to Provide Free COVID-19 Rapid Tests
drugs.com
February 04, 2022
Medicare will soon provide up to eight free COVID-19 rapid tests a month to seniors enrolled..
-
B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site
contractpharma
February 03, 2022
Increased availability of IV solutions to address shortages stemming from ongoing COVID-19 crisis.
-
Novavax seeks EUA from FDA for Covid-19 vaccine
pharmaceutical-business-review
February 01, 2022
Novavax has submitted a request seeking emergency use authorisation (EUA) from the US Food and Drug Administration...
-
Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022
prnasia
January 29, 2022
Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th...
-
Chinese mainland reports 39 new local COVID-19 cases
NMPA/Xinhua
January 29, 2022
The Chinese mainland on Thursday recorded 39 locally transmitted COVID-19 cases, the National Health Commission said on Jan 28.
-
Pfizer obtains positive EMA CHMP opinion for oral Covid-19 treatment
Pharmaceutical-Technology
January 29, 2022
The recommendation is based on scientific data including results from the Phase II/III EPIC-HR clinical trial of Paxlovid.
-
BioFlux System Used in Key Studies to Identify Causes and Treatments of Blood Clots Related to COVID-19
prnewswire
January 28, 2022
Fluxion Biosciences announced that its BioFlux system was used in research on COVID-19 and its ability to lead to high levels of platelet coagulation and an increased risk of thrombosis.
-
OPEC Fund provides US$1.5bn in new development financing in 2021, deepens impact and fully utilizes COVID-19 facility
prnewswire
January 28, 2022
With a total of US$1.5 billion committed in 2021, the OPEC Fund for International Development made a strong contribution to the global development agenda last year.
-
BerGenBio and Oslo University Hospital Announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded EU-SolidAct trial in Hospitalised COVID-19 Patients
prnewswire
January 28, 2022
BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs and Oslo University Hospital announced today...